Archives
ENDO: Fezolinetant Cuts Vasomotor Symptoms in Menopause
Frequency and severity of vasomotor symptoms reduced with fezolinetant versus placebo through 12 weeks
Radiographic Findings Described for Salpingography, Recanalization
Patent bilateral normal fallopian tubes achieved in 86.6 and 80.7 percent of patients with primary and secondary infertility, respectively
ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
In phase 2 trial, overall survival longer with combo treatment compared with investigator's choice for standard of care in advanced NSCLC
Hormonal Contraceptives Tied to Lower Suicide Attempt Risk
Risk lower in women with no psychiatric history and particularly those using ethinylestradiol-containing hormonal contraceptives
ASCO: Ancestry-Specific Genetic Risk Examined for TNBC
Magnitudes of gene-specific risks for triple-negative breast cancer similar across racial/ethnic groups
ADA: Insulin Delivery Systems Compared in Type 1 Diabetes
Open-source automated insulin delivery compared to sensor augmented pump therapy in adults and children with T1D
ADA: Diabetes May Quadruple Risk for Long COVID
Authors say review findings are limited by heterogenous definitions of long COVID in published studies
ASCO: Risk for Suicide Elevated in Cancer Patients in the U.S.
Standardized mortality ratio for suicide decreased from 2000 to 2016, but risk remains elevated, especially within first two years of diagnosis
ASCO: ACA Medicaid Expansion Has Increased Access to Cancer Trials
Proportion of SWOG trial participants who had Medicaid insurance increased by 20 percent per year after ACA Medicaid expansion
ASCO: Parental Cancer Tied to Risk for Unmet Social Needs in Children
Unmet social needs include family-level food insecurity, financial worry about housing costs and other monthly bills, and transportation challenges